Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

S0100000

Salbutamol

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

α-[(tert.-Butylamino)-methyl]-4-hydroxy-m-xylol-α,α′-diol, Albuterol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C13H21NO3
CAS-Nummer:
18559-94-9
Molekulargewicht:
239.31
Beilstein:
6405698
MDL-Nummer:
MFCD00148978
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329824412
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

albuterol, salbutamol

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

CC(C)(C)NCC(O)c1ccc(O)c(CO)c1

InChI

1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3

InChIKey

NDAUXUAQIAJITI-UHFFFAOYSA-N

Angaben zum Gen

human ... ADRB2(154)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Salbutamol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem./physiol. Wirkung

β2-Adrenoceptor Agonist

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1053

Albuterolsulfat, Pharmaceutical Secondary Standard; Certified Reference Material

S0150000

Salbutamolsulfat, European Pharmacopoeia (EP) Reference Standard

Y0000034

Salbutamol Unreinheit G, European Pharmacopoeia (EP) Reference Standard

Y0000030

Salbutamol Unreinheit B, European Pharmacopoeia (EP) Reference Standard

Y0000031

Salbutamol Unreinheit F, European Pharmacopoeia (EP) Reference Standard

Y0000071

Salbutamol Unreinheit D, European Pharmacopoeia (EP) Reference Standard

Y0000032

Salbutamol Unreinheit I, European Pharmacopoeia (EP) Reference Standard

Y0001186

Salbutamol Unreinheit J, European Pharmacopoeia (EP) Reference Standard

Y0001288

Salbutamolsulfat für die Systemeignung, European Pharmacopoeia (EP) Reference Standard

1012633

Albuterolsulfat, United States Pharmacopeia (USP) Reference Standard

1358784

Levalbuterol -hydrochlorid, United States Pharmacopeia (USP) Reference Standard

1012600

Albuterol, United States Pharmacopeia (USP) Reference Standard

1012644

Albuterol-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

1012655

Albuterol-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

1012689

Albuterol-verwandte Verbindung E, United States Pharmacopeia (USP) Reference Standard

BP451

Salbutamol, British Pharmacopoeia (BP) Reference Standard

BP302

Salbutamol-Sulfat, British Pharmacopoeia (BP) Reference Standard

PHR1960

Salbutamol-Unreinheit D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2040

Albuterol-verwandte Verbindung B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1961

Salbutamol-Unreinheit G, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1962

Salbutamol-Unreinheit I, Pharmaceutical Secondary Standard; Certified Reference Material

BP712

Salbutamol-Aldehyd-Unreinheit, British Pharmacopoeia (BP) Reference Standard

BP192

2-tert-Butylamino-1-(4-Hydroxy-3-methylphenyl)ethanolsulfat, British Pharmacopoeia (BP) Reference Standard

BP852

Salbutamol-Unreinheit B, British Pharmacopoeia (BP) Reference Standard

BP704

Salbutamol-Keton-Unreinheit, British Pharmacopoeia (BP) Reference Standard

PHR2106

4-[2-[(1,1-Dimethylethyl)amino]ethyl]-2-methylphenol, Pharmaceutical Secondary Standard; Certified Reference Material

PHR9050

4-[2-(tert.-Butylamino)-1-methoxyethyl]-2-(hydroxymethyl)-phenol, reference material, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR9071

4-[2-[Benzyl-(tert.-butyl)-amino]-1-hydroxyethyl]-2-(hydroxymethyl)-phenol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

1012564

Albuterol Related Compound I, United States Pharmacopeia (USP) Reference Standard

PHR2332

Methyl5-[2-[benzyl(tert-butyl)amino]acetyl]-2-hydroxybenzoate hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

Gefahreneinstufungen

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Skin Sens. 1B

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

L Gnatiuc et al.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 19(1), 21-30 (2014-12-19)
Increasing access to essential respiratory medicines and influenza vaccination has been a priority for over three decades. Their use remains low in low- and middle-income countries (LMICs), where little is known about factors influencing use, or about the use of
M Reza Maleki-Yazdi et al.
Respiratory medicine, 108(12), 1752-1760 (2014-12-03)
Combinations of inhaled long-acting bronchodilator therapies such as muscarinic antagonists and β2-agonists may be more effective than monotherapy in the treatment of chronic obstructive pulmonary disease (COPD). This study was a 24-week, Phase III, multicenter, randomized, blinded, double-dummy, parallel-group study
The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta-adrenoceptor agonists.
D Jack
British journal of clinical pharmacology, 31(5), 501-514 (1991-05-01)
Karim Makhlouf et al.
CNS drugs, 16(1), 1-8 (2002-01-05)
The beta2-adrenergic receptor agonist salbutamol (albuterol) has been used for many years in the treatment of bronchospasm in patients with asthma. In this patient group, salbutamol is a relatively safe and inexpensive drug, and is easy to administer. Within the
Thomas Ritz et al.
Chest, 146(5), 1237-1247 (2014-08-15)
Hyperventilation has been associated with adverse effects on lung function, symptoms, and well-being in asthma. We examined whether raising end-tidal CO2 levels (ie, Pco2) compared with slow breathing is associated with improvements in asthma control, including peak flow variability. One
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.